Therapy Areas: Infectious Diseases
19 September 2017 - - US-based biopharmaceutical company Symbiomix Therapeutics has received US Food and Drug Administration (FDA) approval for Solosec (secnidazole) 2g oral granules for the treatment...
15 September 2017 - - New York, New York-based computational genomics company Phosphorus has expanded its catalogue with the addition of an ophthalmologic test for inherited conditions associated...
15 September 2017 - Integrated biotechnology company Bavarian Nordic A/S (CPH:BAVA)(OTC: BVNRY) announced on Thursday that an independent Data Monitoring Committee (DMCB) has determined, based on a pr...
14 September 2017 - - US-based antibiotic developer Geom Therapeutics, Inc. has signed a clinical trial agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of the Na...
13 September 2017 - - US-based biotech company Cancer Prevention Pharmaceuticals, Inc has received a total of USD 9.5m from its North America commercialization partner Sucampo Pharmaceuticals, Inc. (N...
13 September 2017 - - The global biopharmaceutical contract manufacturing market is estimated to be valued at USD 5,625m by the end of 2017 and this is expected to increase to USD 15,467.8m ...